title: Melphalan, Antimelanoma Immunity, and Inflammation--Letter.
authors.affiliation: Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.
authors.forename: Anna
authors.initials: A
authors.lastname: Martner
authors.affiliation: Sahlgrenska Cancer Center, University of Gothenburg, Gothenburg, Sweden.
authors.forename: Junko
authors.initials: J
authors.lastname: Johansson
authors.affiliation: Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden.
authors.forename: Ilan
authors.initials: I
authors.lastname: Ben-Shabat
authors.affiliation: Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg, Sweden. roger.olofsson@surgery.gu.se.
authors.forename: Roger Olofsson
authors.initials: RO
authors.lastname: Bagge
mesh_terms: D000818:Animals; D000954:Antigens, Surface / Q000502:physiology*; D018906:Antineoplastic Agents, Alkylating / Q000494:pharmacology*; D037282:Calreticulin / Q000502:physiology*; D006801:Humans; D008545:Melanoma / Q000276:immunology*; D008558:Melphalan / Q000494:pharmacology*; D012878:Skin Neoplasms / Q000276:immunology*
chemical_list: D000954:Antigens, Surface; D018906:Antineoplastic Agents, Alkylating; D037282:Calreticulin; D008558:Melphalan